Faculty of Veterinary Medicine, University of Calgary, Calgary, Alberta, Canada.
School of Veterinary Science, Faculty of Science, University of Queensland, Gatton, Queensland, Australia.
J Vet Intern Med. 2024 Mar-Apr;38(2):1214-1223. doi: 10.1111/jvim.16983. Epub 2024 Jan 11.
Nebulized administration of dexamethasone on cytokine regulation in horses with moderate asthma has not been investigated.
To investigate the changes in expression of inflammatory cytokine mRNA after nebulized administration of dexamethasone treatment of horses with moderate asthma.
Horses with naturally occurring moderate asthma (n = 16) and healthy control horses (n = 4). All horses were kept in a dusty environment during the study.
Prospective, parallel, randomized, controlled, blinded clinical trial. Blood endogenous cortisol, tracheal mucus, and bronchoalveolar lavage (BAL) were sampled before and after 13 days treatment with either nebulized administration of dexamethasone (15 mg once daily) or 0.9% saline (3 mL). Treatment groups were randomly allocated via randomization function (Microsoft Excel). Amplification of target mRNA in BAL fluid (IL-1β, IL-4, IL-5, IL-6, IL-8, IL-10, IL-12, IL-17, IL-23, IFN-γ, Eotaxin-2, and TNF-α) was achieved by qPCR, and the relative expression software tool was used to analyze BAL inflammatory cytokine mRNA.
Horses treated with nebulized administration of dexamethasone had increased relative expression of IL-5 (1.70-fold), IL-6 (1.71-fold), IL-17 (3.25-fold), IL-12 (1.66-fold), and TNF-α (1.94-fold), and decreased relative expression of IL-23 (1.76-fold; P = .04) in samples collected on Day 14, in comparison to samples collected on Day 0 (all P < .05). Horses treated with nebulized administration of saline had no significant difference in the relative expression of any gene (all P > .05).
Nebulized administration of dexamethasone was associated with increased expression of inflammatory cytokine mRNA. There was no improvement in inflammatory airway cytology associated with either dexamethasone or saline treatment.
雾化给予地塞米松治疗中度哮喘马的细胞因子调节尚未被研究。
研究雾化给予地塞米松治疗中度哮喘马后炎症细胞因子 mRNA 表达的变化。
自然发生中度哮喘的马(n=16)和健康对照马(n=4)。在研究期间,所有马都被置于充满灰尘的环境中。
前瞻性、平行、随机、对照、双盲临床试验。在 13 天的治疗前后,分别采集雾化给予地塞米松(15mg 每日 1 次)或 0.9%生理盐水(3mL)治疗的马的气管内黏液和支气管肺泡灌洗液(BAL)的内源性皮质醇、和 BAL 样本。通过随机数生成函数(Microsoft Excel)对治疗组进行随机分配。通过 qPCR 扩增 BAL 液中的靶 mRNA(IL-1β、IL-4、IL-5、IL-6、IL-8、IL-10、IL-12、IL-17、IL-23、IFN-γ、Eotaxin-2 和 TNF-α),并使用相对表达软件工具分析 BAL 炎症细胞因子 mRNA。
与第 0 天(所有 P<0.05)相比,接受雾化地塞米松治疗的马在第 14 天采集的样本中,IL-5(1.70 倍)、IL-6(1.71 倍)、IL-17(3.25 倍)、IL-12(1.66 倍)和 TNF-α(1.94 倍)的相对表达增加,而 IL-23 的相对表达减少(1.76 倍;P=0.04)。接受雾化生理盐水治疗的马没有任何基因的相对表达有显著差异(所有 P>0.05)。
雾化给予地塞米松与炎症细胞因子 mRNA 表达增加有关。无论是地塞米松还是生理盐水治疗都没有改善炎症性气道细胞学。